Melanoma Cells Break Down LPA to Establish Local Gradients That Drive Chemotactic Dispersal

PLoS Biology

Volumn 12, Issue 10, 2014, Pages

  Muinonen Martin, Andrew J ^a,b,c   Susanto, Olivia ^a   Zhang, Qifeng ^d   Smethurst, Elizabeth ^d   Faller, William J ^a   Veltman, Douwe M ^a   Kalna, Gabriela ^a   Lindsay, Colin ^a,e   Bennett, Dorothy C ^f   Sansom, Owen J ^a   Herd, Robert ^g   Jones, Robert ^a,e   Machesky, Laura M ^a   Wakelam, Michael J O ^d   Knecht, David A ^h   Insall, Robert H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d BABRAHAM INSTITUTE   (United Kingdom)

^e BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g Alan Lyell Centre for Dermatology   (United Kingdom)

^h UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; PLATELET DERIVED GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; LYSOPHOSPHOLIPID; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CELL DENSITY; CELL INVASION; CELL MOTILITY; CELL POPULATION; CELL SPREADING; CELL SURVIVAL; CHEMOTAXIS; CONTACT INHIBITION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MASS SPECTROMETRY; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN FUNCTION; TUMOR GROWTH; ANIMAL; CELL MOTION; MELANOMA; METABOLISM;

ANIMALS; CELL MOVEMENT; CHEMOTAXIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MELANOMA; MICE; NEOPLASM METASTASIS;

EID: 84920485053     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001966     Document Type: Article

References (57)

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199–6206.
2. Langley RR, Fidler IJ, (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28: 297–321.
3. Payette MJ, Katz M, Grant-Kels JM, (2009) Melanoma prognostic factors found in the dermatopathology report. Clin Dermatol 27: 53–74.
4. Sleeman J, Steeg PS, (2010) Cancer metastasis as a therapeutic target. Eur J Cancer 46: 1177–1180.
5. Sleeman JP, (2012) Metastasis: understanding is the beginning of order in chaos. Semin Cancer Biol 22: 173.
6. Parichy DM, Reedy MV, Erickson CA (2006) Regulation of melanoblast migration and differentiation. Nordland JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system and its disorders, 2nd edition. Oxford: Oxford University Press. pp. 108–139.
7. Condeelis J, Singer RH, Segall JE, (2005) The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 21: 695–718.
8. Hughes-Alford SK, Lauffenburger DA, (2012) Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer. Curr Opin Cell Biol 24: 284–291.
9. Price JT, Tiganis T, Agarwal A, Djakiew D, Thompson EW, (1999) Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res 59: 5475–5478.
10. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, et al. (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64: 7022–7029.
11. Wach F, Eyrich AM, Wustrow T, Krieg T, Hein R, (1996) Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro. J Dermatol Sci 12: 118–126.
12. Lee E, Han J, Kim K, Choi H, Cho EG, et al. (2013) CXCR7 mediates SDF1-induced melanocyte migration. Pigment Cell Melanoma Res 26: 58–66.
13. Roussos ET, Condeelis JS, Patsialou A, (2011) Chemotaxis in cancer. Nat Rev Cancer 11: 573–587.
14. Zigmond SH, Hirsch JG, (1973) Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med 137: 387–410.
15. Muinonen-Martin AJ, Veltman DM, Kalna G, Insall RH, (2010) An improved chamber for direct visualisation of chemotaxis. PLoS ONE 5: e15309.
16. Zicha D, Dunn GA, Brown AF, (1991) A new direct-viewing chemotaxis chamber. J Cell Sci 99: 769–775.
17. Zigmond SH, (1974) Mechanisms of sensing chemical gradients by polymorphonuclear leukocytes. Nature 249: 450–452.
18. Griffith CK, Miller C, Sainson RCA, Calvert JW, Jeon NL, et al. (2005) Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11: 257–266.
19. Dona E, Barry JD, Valentin G, Quirin C, Khmelinskii A, et al. (2013) Directional tissue migration through a self-generated chemokine gradient. Nature 503: 285–289.
20. Valentin G, Haas P, Gilmour D, (2007) The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr Biol 17: 1026–1031.
21. Venkiteswaran G, Lewellis SW, Wang J, Reynolds E, Nicholson C, et al. (2013) Generation and dynamics of an endogenous, self-generated signaling gradient across a migrating tissue. Cell 155: 674–687.
22. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, et al. (1985) Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45: 5670–5676.
23. Abercrombie M, (1970) Contact inhibition in tissue culture. In Vitro 6: 128–142.
24. Carmona-Fontaine C, Matthews HK, Kuriyama S, Moreno M, Dunn GA, et al. (2008) Contact inhibition of locomotion in vivo controls neural crest directional migration. Nature 456: 957–961.
25. Zaki M, Andrew N, Insall RH, (2006) Entamoeba histolytica cell movement: a central role for self-generated chemokines and chemorepellents. Proc Natl Acad Sci U S A 103: 18751–18756.
26. Scherber C, Aranyosi AJ, Kulemann B, Thayer SP, Toner M, et al. (2012) Epithelial cell guidance by self-generated EGF gradients. Integr Biol (Camb) 4: 259–269.
27. Haugh JM, (2006) Deterministic model of dermal wound invasion incorporating receptor-mediated signal transduction and spatial gradient sensing. Biophys J 90: 2297–2308.
28. Devreotes PN, Zigmond SH, (1988) Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu Rev Cell Biol 4: 649–686.
29. Zicha D, Dunn GA, (1995) Are growth factors chemotactic agents? Exp Cell Res 221: 526–529.
30. Berens P, (2009) CircStat: a MATLAB toolbox for circular statistics. J Stat Softw 31: 1–21.
31. Murata J, Saiki I, Yoneda J, Azuma I, (1992) Differences in chemotaxis to fibronectin in weakly and highly metastatic tumor cells. Jpn J Cancer Res 83: 1327–1333.
32. Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Huttelmaier S, et al. (2002) Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 62: 6278–6288.
33. Mackenzie Ross AD, Cook MG, Chong H, Hossain M, Pandha HS, et al. (2013) Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression. Pigment Cell Melanoma Res 26: 226–235.
34. Condeelis J, Pollard JW, (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263–266.
35. Toyozawa S, Kaminaka C, Furukawa F, Nakamura Y, Matsunaka H, et al. (2012) Chemokine receptor CXCR4 is a novel marker for the progression of cutaneous malignant melanomas. Acta Histochem Cytochem 45: 293–299.
36. Houben AJ, Moolenaar WH, (2011) Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev 30: 557–565.
37. Jongsma M, Matas-Rico E, Rzadkowski A, Jalink K, Moolenaar WH, (2011) LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. PLoS ONE 6: e29260.
38. Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS, (2006) Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol 24: 79–88.
39. Toetsch S, Olwell P, Prina-Mello A, Volkov Y, (2009) The evolution of chemotaxis assays from static models to physiologically relevant platforms. Integr Biol (Camb) 1: 170–181.
40. Timpson P, McGhee EJ, Erami Z, Nobis M, Quinn JA, et al. (2011) Organotypic collagen I assay: a malleable platform to assess cell behaviour in a 3-dimensional context. J Vis Exp e3089.
41. Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smit DJ, et al. (2002) Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells. Cancer Res 62: 226–232.
42. Aaltonen N, Laitinen JT, Lehtonen M, (2010) Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878: 1145–1152.
43. Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H, et al. (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478: 159–165.
44. Parrill AL, (2008) Lysophospholipid interactions with protein targets. Biochim Biophys Acta 1781: 540–546.
45. Jalink K, Hengeveld T, Mulder S, Postma FR, Simon MF, et al. (1995) Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem J 307: 609–616.
46. Jordan SA, Jackson IJ, (2000) MGF (KIT ligand) is a chemokinetic factor for melanoblast migration into hair follicles. Dev Biol 225: 424–436.
47. Snider AJ, Zhang Z, Xie Y, Meier KE, (2010) Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: roles for phospholipase D2 and receptor transactivation. Am J Physiol Cell Physiol 298: C163–C170.
48. Tigyi G, (2010) Aiming drug discovery at lysophosphatidic acid targets. Br J Pharmacol 161: 241–270.
49. Kuriyama S, Theveneau E, Benedetto A, Parsons M, Tanaka M, et al. (2014) In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity. J Cell Biol 206: 113–127.
50. Gotoh M, Fujiwara Y, Yue J, Liu J, Lee S, et al. (2012) Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis. Biochem Soc Trans 40: 31–36.
51. Zhao C, Sardella A, Chun J, Poubelle PE, Fernandes MJ, et al. (2011) TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines. J Lipid Res 52: 1307–1318.
52. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, et al. (2004) Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114: 1714–1725.
53. Sierko E, Wojtukiewicz MZ, (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30: 95–108.
54. Algra AM, Rothwell PM, (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13: 518–527.
55. Theveneau E, Steventon B, Scarpa E, Garcia S, Trepat X, et al. (2013) Chase-and-run between adjacent cell populations promotes directional collective migration. Nat Cell Biol 15: 763–772.
56. Garcia GL, Rericha EC, Heger CD, Goldsmith PK, Parent CA, (2009) The group migration of dictyostelium cells is regulated by extracellular chemoattractant degradation. Mol Biol Cell 20: 3295–3304.
57. Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41: 544–552.